Our data concur with a previous statin myopathy GWAS,9 as well as our own pilot data9 and other candidate gene studies,4, 5, 8, 20 that the SLCO1B1 c.521C>T polymorphism (rs4149056) is the predominant genetic risk factor for statin‐induced myopathy. This evidence concerns the gene SLCO1B1 and myopathy.